Precigen (PGEN) FY2016 results: revenue $191 million, up 10.0% on the year
Precigen, Inc. (PGEN) reported revenue of $191 million for fiscal 2016, the year ended 31 December 2016, up 10.0% on the year before. Net income was -$187 million, and diluted earnings per share $-1.58. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2017.
Revenue
$191 million
+10.0% on the year
FY2011FY2016
Operating margin
-65.6%
-84.6% a year earlier
FY2011FY2016
Net income
-$187 million
FY2011FY2016
Diluted EPS
-$1.58
FY2011FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
191
174
71.9
+10.0%
Cost of revenue
61.6
63.9
19.3
-3.6%
Gross profit
129
110
52.7
+17.9%
Gross margin
67.7%
63.2%
73.2%
Research and development
112
147
59.0
-24.0%
Selling, general and administrative
142
109
63.6
+30.5%
Operating income
-125
-147
-70.0
Operating margin
-65.6%
-84.6%
-97.3%
Interest expense
0.9
1.2
0.7
-30.8%
Pre-tax income
-194
-87.0
-85.7
Income tax
-3.9
1.0
-0.1
Net income
-187
-84.5
-81.8
Net margin
-97.7%
-48.7%
-113.8%
Diluted EPS
-$1.58
-$0.76
-$0.83
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
-49.0
35.7
-19.9
Capital expenditure
31.6
12.7
6.4
+148.1%
Free cash flow
-80.6
22.9
-26.2
Free cash flow margin
-42.2%
13.2%
-36.5%
Cash from investing
-28.4
-259
-26.0
Cash from financing
12.1
332
24.0
-96.4%
Depreciation and amortisation
24.6
17.7
10.4
+38.5%
Share-based compensation
42.2
38.7
21.8
+9.1%
Shares outstanding at period end
119m
117m
101m
+1.7%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
560
694
385
-19.3%
Non-controlling interest
9.0
10.8
24.5
-16.6%
Debt
7.9
8.5
12.6
-6.8%
Other liabilities
372
269
154
+38.4%
Total liabilities and equity
949
982
576
-3.4%
Fixed assets
64.7
42.7
38.0
+51.3%
Goodwill
157
165
101
-4.8%
Intangible assets
226
248
65.9
-8.9%
Investments
181
208
116
-13.2%
Cash and equivalents
62.6
136
27.5
-53.9%
Receivables
21.6
25.1
14.6
-13.8%
Other assets
237
158
214
+50.1%
Total assets
949
982
576
-3.4%
10-K for the year ended 31 December 2016, filed 1 March 2017: the filing.